Pathstone Family Office’s Evolv Technologies EVLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$289K Buy
59,527
+8,118
+16% +$50K ﹤0.01% 1333
2023
Q2
$308K Hold
51,409
– – ﹤0.01% 953
2023
Q1
$160K Sell
51,409
-20,268
-28% -$57.9K ﹤0.01% 1109
2022
Q4
$166K Sell
71,677
-60,801
-46% -$179K ﹤0.01% 1126
2022
Q3
$281K Hold
132,478
– – 0.01% 954
2022
Q2
$352K Hold
132,478
– – 0.01% 719
2022
Q1
$352K Buy
132,478
+115,478
+679% +$378K 0.01% 685
2021
Q4
$76K Buy
17,000
+7,000
+70% +$39.3K ﹤0.01% 866
2021
Q3
$60K Buy
+10,000
New +$79.3K ﹤0.01% 845

Other funds holding EVLV

Pathstone Family Office's EVLV Position: Q3 2023 in Review

Pathstone Family Office increased its Evolv Technologies (EVLV) stake by 16% in Q3 2023, buying an estimated $50K and bringing the position to 59,527 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #1333.

Pathstone Family Office first reported a position in EVLV in Q3 2021 and has held it in 9 quarters since. The position peaked at $352K in Q2 2022. 175 funds tracked by Wall St. Rank hold EVLV as of Q3 2023.

  • Pathstone Family Office held 59,527 shares of Evolv Technologies worth $289K as of Q3 2023.
  • Pathstone Family Office bought 8,118 Evolv Technologies shares in Q3 2023, an estimated $50K.
  • Evolv Technologies made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1333 holding.
  • Pathstone Family Office first reported a position in Evolv Technologies in Q3 2021 and has held it in 9 quarters since.
  • Pathstone Family Office's Evolv Technologies position peaked at $352K in Q2 2022.
  • 175 funds tracked by Wall St. Rank held Evolv Technologies as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.